ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:07
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual drug analysis: 330


Drug details and screening numbers

Drug Name: XMD13-2
Drug ID: 330
Synonyms:
Brand name:
Target: RIPK

Number of cell lines screened: 923
Screening concentration range(s): 0.04 to 10.24 uM


Statistically significant associations identified = 5
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a68
EWSR1-FLI1_mut
330
1
1
XMD13-2
RIPK
17
903
2.33
3.39
2.03
-1.36
1 *
1 *
1.2 *
2.78e-06
1.46e-57
7.47e-01
0.67
a166
MLL2_mut
330
1
1
XMD13-2
RIPK
97
823
2.33
3.44
2.67
-0.774
0.59 .
0.59 .
0.58 .
5.28e-05
3.39e-57
7.47e-01
5.2
a367
loss_cnaPANCAN233
330
1
1
XMD13-2
RIPK
47
873
2.33
3.32
4.15
0.831
0.63 .
0.63 .
0.7 .
3.73e-04
5.88e-57
7.48e-01
17
a452
loss_cnaPANCAN227, loss_cnaPANCAN228
330
1
1
XMD13-2
RIPK
29
891
2.33
3.33
4.42
1.09
0.82 .
0.82 .
0.97 .
5.81e-04
6.65e-57
7.48e-01
21
a463
loss_cnaPANCAN234
330
1
1
XMD13-2
RIPK
44
876
2.33
3.32
4.11
0.789
0.6 .
0.59 .
0.65 .
6.02e-04
6.72e-57
7.48e-01
21


All-tests volcano plot